Akèy › Amiloidoz › Massachusetts › Boston
Etid klinik pou Amiloidoz nan Boston, MA
11 etid pou Amiloidoz ap chèche patisipan nan sit nan ak bò kote Boston (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
Non-interventional Study of Patients With Transthyretin (ATTR) Amyloidosis
Ap rekriteEtid obsèvasyon
- Research Site, Boston
- Research Site, Boston
- Research Site, Boston
TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy
Ap rekriteFaz 3
- Clinical Trial Site, Boston
- Clinical Trial Site, Boston
TRITON-PN: A Study to Evaluate the Efficacy and Safety of Nucresiran in Patients With Hereditary Transthyretin Amyloidosis With Polyneuropathy
Ap rekriteFaz 3
- Clinical Trial Site, Boston
DemonsTTRate: A Global, Observational, Multicenter, Long-term Study of Patients With ATTR-CM in a Real-World Setting
Ap rekriteEtid obsèvasyon
- Clinical Trial Site, Boston
Prevalence and Prediction of ATTR in Ambulatory Patients With HFpEF
Ap rekrite
- Massachusetts General Hospital, Boston
Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
Ap rekriteFaz 3
- Massachusetts General Hospital, Boston
- Brigham and Women's Hospital, Boston
- Boston University (BU) School of Medicine, Boston
[64Cu]FBP8 PET for Early Detection of Intracardiac Thrombus in Amyloid Cardiomyopathy
Ap rekriteFaz 3
- Brigham and Women's Hospital, Boston
A Phase 1b/2 Study of CAR T Cell Therapy Targeting CD19 and BCMA in Participants With Relapsed or Refractory AL Amyloidosis.
Ap rekriteFaz 1/2
- Research Site, Boston
A Study to Assess Change in Disease Activity and Adverse Events (AE)s in Adult Participants With Immunoglobulin Light Chain (AL) Amyloidosis Receiving Etentamig (ABBV-383) as an Intravenous (IV) Infusion
Ap rekriteFaz 1/2
- Boston Medical Center /ID# 255066, Boston
MAGNITUDE: A Phase 3 Study of NTLA-2001 in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM)
Ap rekriteFaz 3
- Brigham and Women's Hospital, Boston
- Boston University School of Medicine, Boston
Molecular Imaging of Primary Amyloid Cardiomyopathy
Ap rekrite
- Brigham and Womens' Hospital, Boston
Etid Amiloidoz nan lòt vil
- Rochester, MN10 etid
- New York City, NY10 etid
- Dallas, TX9 etid
- Philadelphia, PA7 etid
- Houston, TX6 etid
- Baltimore, MD6 etid
- Durham, NC6 etid
- Portland, OR6 etid
- St. Louis, MO6 etid
- San Diego, CA5 etid
- Cleveland, OH5 etid
- Chicago, IL5 etid
Lòt etid nan Boston
- Kansè nan tete111 etid
- Kansè Poumon ki pa ti selil90 etid
- Kansè (tout kalite)86 etid
- Kansè kolorektal63 etid
- Kansè Metastatik63 etid
- Kansè poumon62 etid
- Kansè ovè61 etid
- Kansè pwostat59 etid
- Depresyon52 etid
- Kansè Endomèt50 etid
- Ensifizyans kadyak44 etid
- Leksemi mieloïd egi44 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.